Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morris J Robins

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Medicinal Chemistry|August 20, 2010
Improved syntheses of 5'-S-(2-aminoethyl)-6-N-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), analogues, and fluorescent probe conjugates: analysis of cell-surface human equilibrative nucleoside transporter 1 (hENT1) levels for prediction of the antitumor efficacy of gemcitabineMorris J Robins, Yunshan Peng, Vijaya L Damaraju, et al.
Journal of Medicinal Chemistry|January 6, 2006
Synthesis and biological evaluation of 6-(alkyn-1-yl)furo[2,3-d]pyrimidin-2(3H)-one base and nucleoside derivativesMorris J Robins, Karl Miranda, Vivek K Rajwanshi, et al.
Biochemical Pharmacology|September 22, 2010
Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1Vijaya L Damaraju, Kyla M Smith, Delores Mowles, et al.
The Journal of Biological Chemistry|March 24, 2007
Residues 334 and 338 in transmembrane segment 8 of human equilibrative nucleoside transporter 1 are important determinants of inhibitor sensitivity, protein folding, and catalytic turnoverFrank Visser, Lijie Sun, Vijaya Damaraju, et al.
Journal of Medicinal Chemistry|July 12, 2007
Synthesis and antiviral evaluation of 6-(alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one nucleosides and analogues with ethynyl, ethenyl, and ethyl spacers at C6 of the furopyrimidine coreMorris J Robins, Ireneusz Nowak, Vivek K Rajwanshi, et al.
Biochemistry|January 25, 2006
Studies of nucleoside transporters using novel autofluorescent nucleoside probesJing Zhang, Xuejun Sun, Kyla M Smith, et al.
Molecular Pharmacology|December 4, 2003
Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiaeJing Zhang, Frank Visser, Mark F Vickers, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2004
Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiaeMark F Vickers, Jing Zhang, Frank Visser, et al.
Molecular Pharmacology|June 16, 2005
Uridine binding and transportability determinants of human concentrative nucleoside transportersJing Zhang, Kyla M Smith, Tracey Tackaberry, et al.
The Journal of Biological Chemistry|July 21, 2006
Characterization of the transport mechanism and permeant binding profile of the uridine permease Fui1p of Saccharomyces cerevisiaeJing Zhang, Kyla M Smith, Tracey Tackaberry, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Medicinal Chemistry|August 20, 2010
Improved syntheses of 5'-S-(2-aminoethyl)-6-N-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), analogues, and fluorescent probe conjugates: analysis of cell-surface human equilibrative nucleoside transporter 1 (hENT1) levels for prediction of the antitumor efficacy of gemcitabineMorris J Robins, Yunshan Peng, Vijaya L Damaraju, et al.
Journal of Medicinal Chemistry|January 6, 2006
Synthesis and biological evaluation of 6-(alkyn-1-yl)furo[2,3-d]pyrimidin-2(3H)-one base and nucleoside derivativesMorris J Robins, Karl Miranda, Vivek K Rajwanshi, et al.
Biochemical Pharmacology|September 22, 2010
Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1Vijaya L Damaraju, Kyla M Smith, Delores Mowles, et al.
The Journal of Biological Chemistry|March 24, 2007
Residues 334 and 338 in transmembrane segment 8 of human equilibrative nucleoside transporter 1 are important determinants of inhibitor sensitivity, protein folding, and catalytic turnoverFrank Visser, Lijie Sun, Vijaya Damaraju, et al.
Journal of Medicinal Chemistry|July 12, 2007
Synthesis and antiviral evaluation of 6-(alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one nucleosides and analogues with ethynyl, ethenyl, and ethyl spacers at C6 of the furopyrimidine coreMorris J Robins, Ireneusz Nowak, Vivek K Rajwanshi, et al.
Biochemistry|January 25, 2006
Studies of nucleoside transporters using novel autofluorescent nucleoside probesJing Zhang, Xuejun Sun, Kyla M Smith, et al.
Molecular Pharmacology|December 4, 2003
Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiaeJing Zhang, Frank Visser, Mark F Vickers, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2004
Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiaeMark F Vickers, Jing Zhang, Frank Visser, et al.
Molecular Pharmacology|June 16, 2005
Uridine binding and transportability determinants of human concentrative nucleoside transportersJing Zhang, Kyla M Smith, Tracey Tackaberry, et al.
The Journal of Biological Chemistry|July 21, 2006
Characterization of the transport mechanism and permeant binding profile of the uridine permease Fui1p of Saccharomyces cerevisiaeJing Zhang, Kyla M Smith, Tracey Tackaberry, et al.
Pageof 5